{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:10:55Z","timestamp":1775085055475,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Short Form Qualiveen (SF-Qualiveen) questionnaire assesses the effect of bladder and urinary symptoms on patients\u2019 quality of life (QoL) with urological impairment caused by neurological diseases. There is no validated SF-Qualiveen questionnaire in Arabic, so this study aims to provide a translated and validated version of the SF-Qualiveen questionnaire among Arabic-speaking patients with multiple sclerosis (MS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The English version of the SF-Qualiveen was translated into Arabic using an algorithm for linguistic and cultural adaptation. MS patients completed the SF-Qualiveen, and the Neurogenic Bladder Symptom Score(NBSS) questionnaire. Psychometric features such as content and construct validity, test\u2013retest reliability, and internal consistency were analyzed. Construct validity was evaluated by contrasting the SF-Qualiveen with the NBSS questionnaire. Internal consistency was measured using Cronbach\u2019s alpha, whereas the intraclass correlation coefficient (ICC) was employed to assess the test-retest reliability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred and two patients with MS were included in this study. The internal consistency of the total SF-Qualiveen, and the domains \u201cBother with limitations,\u201d \u201cFear,\u201d \u201cFeeling,\u201d and \u201cFrequency of limitations\u201d showed good internal consistency (Cronbach\u2019s alpha of &gt;\u20090.7). ICC was 0.91 for the total score 0.85 for the Bother with limitations, 0.81 for Fears, 0.86 for Feeling, and 0.81 for Frequency of limitations. The correlation analysis revealed a positive association between the total scores on the NBSS and the domains of the SF-Qualiveen, comprising bother with limitations (<jats:italic>r<\/jats:italic>\u2009=\u20090.473, <jats:italic>p<\/jats:italic>\u2009=\u20090.027), fears (<jats:italic>r<\/jats:italic>\u2009=\u20090.611, <jats:italic>p<\/jats:italic>\u2009=\u20090.031), feelings (<jats:italic>r<\/jats:italic>\u2009=\u20090.572, <jats:italic>p<\/jats:italic>\u2009=\u20090.04), and frequency of limitations (<jats:italic>r<\/jats:italic>\u2009=\u20090.514, <jats:italic>p<\/jats:italic>\u2009=\u20090.013).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The findings of this validation study revealed that the SF-Qualiveen is a reliable and valid instrument appropriate for Arabic-speaking patients with MS in both research and clinical practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-024-01429-4","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T14:03:29Z","timestamp":1707746609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arabic version of the SF-Qualiveen: cross-cultural adaptation, translation, and validation of urinary disorder\u2010specific instruments in patients with multiple sclerosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Younes A.","family":"Khadour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fater A.","family":"Khadour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"1429_CR1","doi-asserted-by":"publisher","unstructured":"de S\u00e8ze M, Ruffion A, Denys P, Joseph P-A, Perrouin-Verbe B. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines., Mult. Scler, vol. 13, no. 7, pp. 915\u2013928, Aug. 2007, https:\/\/doi.org\/10.1177\/1352458506075651.","DOI":"10.1177\/1352458506075651"},{"key":"1429_CR2","doi-asserted-by":"publisher","unstructured":"Solaro C et al. Aug., Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire)., J. Neurol. Sci, vol. 331, no. 1\u20132, pp. 94\u201397, 2013, https:\/\/doi.org\/10.1016\/j.jns.2013.05.020.","DOI":"10.1016\/j.jns.2013.05.020"},{"key":"1429_CR3","doi-asserted-by":"publisher","unstructured":"Kondo A, Kamihira O, Ozawa H. Neural tube defects: prevalence, etiology and prevention. Int J Urol off J Japanese Urol Assoc. Jan. 2009;16(1):49\u201357. https:\/\/doi.org\/10.1111\/j.1442-2042.2008.02163.x.","DOI":"10.1111\/j.1442-2042.2008.02163.x"},{"key":"1429_CR4","doi-asserted-by":"publisher","unstructured":"Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don\u2019t agree: cross sectional study of patients\u2019 and doctors\u2019 perceptions and assessments of disability in multiple sclerosis. BMJ. May 1997;314(7094):1580\u20133. https:\/\/doi.org\/10.1136\/bmj.314.7094.1580.","DOI":"10.1136\/bmj.314.7094.1580"},{"key":"1429_CR5","doi-asserted-by":"publisher","unstructured":"Groen J, et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol. Feb. 2016;69(2):324\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2015.07.071.","DOI":"10.1016\/j.eururo.2015.07.071"},{"key":"1429_CR6","doi-asserted-by":"publisher","unstructured":"Clark R, Welk B. Patient reported outcome measures in neurogenic bladder. Transl Androl Urol. Feb. 2016;5(1):22\u201330. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2015.12.05.","DOI":"10.3978\/j.issn.2223-4683.2015.12.05"},{"key":"1429_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/RRU.S51020","volume":"5","author":"B Welk","year":"2013","unstructured":"Welk B, Morrow SA, Madarasz W, Potter P, Sequeira K. The conceptualization and development of a patient-reported neurogenic bladder symptom score. Res Rep Urol. 2013;5:129\u201337. https:\/\/doi.org\/10.2147\/RRU.S51020.","journal-title":"Res Rep Urol"},{"key":"1429_CR8","doi-asserted-by":"publisher","unstructured":"Costa P et al. Jan., Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen., Eur. Urol, vol. 39, no. 1, pp. 107\u2013113, 2001, https:\/\/doi.org\/10.1159\/000052421.","DOI":"10.1159\/000052421"},{"key":"1429_CR9","doi-asserted-by":"publisher","unstructured":"Bonniaud V, Parratte B, Amarenco G, Jackowski D, Didier J-P, Guyatt G. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire., Arch. Phys. Med. Rehabil, vol. 85, no. 8, pp. 1317\u20131323, Aug. 2004, https:\/\/doi.org\/10.1016\/j.apmr.2003.09.029.","DOI":"10.1016\/j.apmr.2003.09.029"},{"key":"1429_CR10","doi-asserted-by":"publisher","unstructured":"Welk B, Morrow S, Madarasz W, Baverstock R, Macnab J, Sequeira K. The validity and reliability of the neurogenic bladder symptom score. J Urol. Aug. 2014;192(2):452\u20137. https:\/\/doi.org\/10.1016\/j.juro.2014.01.027.","DOI":"10.1016\/j.juro.2014.01.027"},{"key":"1429_CR11","doi-asserted-by":"publisher","unstructured":"Khadour YA, Ebrahem BM, Khadour FA. Cross-cultural adaptation, translation, and validation of the Arabic version of the short form of Neurogenic Bladder Symptoms Score., Neurourol. Urodyn, Apr. 2023, https:\/\/doi.org\/10.1002\/nau.25184.","DOI":"10.1002\/nau.25184"},{"key":"1429_CR12","doi-asserted-by":"publisher","unstructured":"Bonniaud V et al. Mar., Quality of life in multiple sclerosis patients with urinary disorders: discriminative validation of the English version of Qualiveen., Qual. life Res. an Int. J. Qual. life Asp. Treat. care Rehabil, vol. 14, no. 2, pp. 425\u2013431, 2005, https:\/\/doi.org\/10.1007\/s11136-004-0686-1.","DOI":"10.1007\/s11136-004-0686-1"},{"key":"1429_CR13","doi-asserted-by":"publisher","unstructured":"Pannek J, M\u00e4rk R, St\u00f6hrer M, Schurch B. [Quality of life in German-speaking patients with spinal cord injuries and bladder dysfunctions. Validation of the German version of the Qualiveen questionnaire]., Urologe. A, vol. 46, no. 10, pp. 1416\u20131421, Oct. 2007, https:\/\/doi.org\/10.1007\/s00120-007-1425-3.","DOI":"10.1007\/s00120-007-1425-3"},{"key":"1429_CR14","doi-asserted-by":"publisher","unstructured":"Bonniaud V et al. Mar., Italian version of Qualiveen-30: cultural adaptation of a neurogenic urinary disorder-specific instrument., Neurourol. Urodyn, vol. 30, no. 3, pp. 354\u2013359, 2011, https:\/\/doi.org\/10.1002\/nau.20967.","DOI":"10.1002\/nau.20967"},{"issue":"1","key":"1429_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11255-008-9402-3","volume":"41","author":"CAL D\u2019Ancona","year":"2009","unstructured":"D\u2019Ancona CAL, et al. Quality of life of neurogenic patients: translation and validation of the Portuguese version of Qualiveen. Int Urol Nephrol. 2009;41(1):29\u201333. https:\/\/doi.org\/10.1007\/s11255-008-9402-3.","journal-title":"Int Urol Nephrol"},{"key":"1429_CR16","doi-asserted-by":"publisher","unstructured":"Ciudin A et al. Apr., Quality of life of multiple sclerosis patients: translation and validation of the Spanish version of Qualiveen., Neurourol. Urodyn, vol. 31, no. 4, pp. 517\u2013520, 2012, https:\/\/doi.org\/10.1002\/nau.21234.","DOI":"10.1002\/nau.21234"},{"issue":"1","key":"1429_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1682\/jrrd.2009.08.0132","volume":"47","author":"S Eyigor","year":"2010","unstructured":"Eyigor S, Karapolat H, Akkoc Y, Yesil H, Ekmekci O. Quality of life in patients with multiple sclerosis and urinary disorders: reliability and validity of turkish-language version of Incontinence Quality of Life Scale. J Rehabil Res Dev. 2010;47(1):67\u201371. https:\/\/doi.org\/10.1682\/jrrd.2009.08.0132.","journal-title":"J Rehabil Res Dev"},{"key":"1429_CR18","doi-asserted-by":"publisher","unstructured":"Bonniaud V, Bryant D, Parratte B, Guyatt G. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen., J. Urol, vol. 180, no. 6, pp. 2592\u20132598, Dec. 2008, https:\/\/doi.org\/10.1016\/j.juro.2008.08.016.","DOI":"10.1016\/j.juro.2008.08.016"},{"key":"1429_CR19","doi-asserted-by":"publisher","unstructured":"Reuvers SHM, Korfage IJ, Scheepe JR, Blok BFM. The urinary-specific quality of life of multiple sclerosis patients: Dutch translation and validation of the SF-Qualiveen., Neurourol. Urodyn, vol. 36, no. 6, pp. 1629\u20131635, Aug. 2017, https:\/\/doi.org\/10.1002\/nau.23168.","DOI":"10.1002\/nau.23168"},{"key":"1429_CR20","doi-asserted-by":"publisher","unstructured":"Konstantinidis C, Tzitzika M, Daoultzis KC, Samarinas M, Giannitsas K, Athanasopoulos A. Translation and cultural adaptation of SF Qualiveen questionnaire in Greek., Eur. J. Phys. Rehabil. Med, vol. 57, no. 4, pp. 639\u2013644, Aug. 2021, https:\/\/doi.org\/10.23736\/S1973-9087.20.06558-2.","DOI":"10.23736\/S1973-9087.20.06558-2"},{"key":"1429_CR21","doi-asserted-by":"publisher","unstructured":"Przydacz M, Kornelak P, Golabek T, Dudek P, Chlosta P. Polish versions of the Qualiveen and the SF-Qualiveen: Translation and validation of urinary disorder-specific instruments in patients with multiple sclerosis., Neurourol. Urodyn, vol. 39, no. 6, pp. 1764\u20131770, Aug. 2020, https:\/\/doi.org\/10.1002\/nau.24419.","DOI":"10.1002\/nau.24419"},{"key":"1429_CR22","doi-asserted-by":"publisher","unstructured":"Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. Apr. 2011;17(2):268\u201374. https:\/\/doi.org\/10.1111\/j.1365-2753.2010.01434.x.","DOI":"10.1111\/j.1365-2753.2010.01434.x"},{"key":"1429_CR23","doi-asserted-by":"publisher","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures., Spine (Phila. Pa 1976)., vol. 25, no. 24, pp. 3186\u20133191, Dec. 2000, https:\/\/doi.org\/10.1097\/00007632-200012150-00014.","DOI":"10.1097\/00007632-200012150-00014"},{"key":"1429_CR24","doi-asserted-by":"publisher","unstructured":"Mokkink LB et al. Jul., The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes., J. Clin. Epidemiol, vol. 63, no. 7, pp. 737\u2013745, 2010, https:\/\/doi.org\/10.1016\/j.jclinepi.2010.02.006.","DOI":"10.1016\/j.jclinepi.2010.02.006"},{"key":"1429_CR25","doi-asserted-by":"publisher","unstructured":"Keszei AP, Novak M, Streiner DL. Introduction to health measurement scales., J. Psychosom. Res, vol. 68, no. 4, pp. 319\u2013323, Apr. 2010, https:\/\/doi.org\/10.1016\/j.jpsychores.2010.01.006.","DOI":"10.1016\/j.jpsychores.2010.01.006"},{"key":"1429_CR26","unstructured":"George MP. D, SPSS for Windows step by step: a simple guide and reference. 2003."},{"key":"1429_CR27","doi-asserted-by":"publisher","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. May 2018;126(5):1763\u20138. https:\/\/doi.org\/10.1213\/ANE.0000000000002864.","DOI":"10.1213\/ANE.0000000000002864"},{"key":"1429_CR28","doi-asserted-by":"publisher","first-page":"p4652439","DOI":"10.1155\/2020\/4652439","volume":"2020","author":"ES Philippova","year":"2020","unstructured":"Philippova ES, Bazhenov IV, Ziryanov AV, Moskvina EY. Evaluation of lower urinary tract dysfunction impact on quality of life in multiple sclerosis patients: Russian translation and validation of SF-Qualiveen. Mult Scler Int. 2020;2020:p4652439. https:\/\/doi.org\/10.1155\/2020\/4652439.","journal-title":"Mult Scler Int"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01429-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T14:05:15Z","timestamp":1707746715000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01429-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01429-4","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki for research involving human subjects. The Ethical Committee approved this study in the Al Baath University Institutional Review Board Consent Letter \u2013 IRB 2023196-S. All our methods were carried out under relevant guidelines and regulations. Informed consent was obtained from all the participants and their legal guardian(s) (illiterate participants). We explained the purpose of the survey to each participant and the way to answer the questionnaire. It was all voluntary; no names were taken, so we provided anonymous data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}